Obesity Surgery

, Volume 18, Issue 2, pp 179–181 | Cite as

Behavior of Type 2 Diabetes Mellitus in Morbid Obese Patients Submitted to Gastric Bypass

  • Cláudio Corá Mottin
  • Alexandre Vontobel Padoin
  • Caroline Eckerdt Schroer
  • Fabiano Trentini Barancelli
  • Luiz Glock
  • Giuseppe Repetto
Research Article

Abstract

Introduction

Surgical treatment of obesity has not only resulted in weight loss, but also the control of associated diseases in the postoperative period. The aim of this study was to determine the post-op response of type 2 diabetes mellitus (DM2) to gastric bypass.

Methods

A historical cohort study was performed involving all the diabetic, morbid obese patients who underwent gastric bypass during the period of May 2000 to October 2006 at the Centro da Obesidade Mórbida. Patient records were reviewed with regard to sex, age, anthropometric measurements, glycemia, glycosylated hemoglobin, pre-op insulin, and DM2 outcome.

Results

A total of 125 diabetic, morbid obese patients were operated; they had a mean age of 42.6 ± 9.7 years and body mass index of 49 ± 8.3 kg/m2. Of these patients, 63 (50.4%) required medication for control of DM2, and the rest managed only with diet.

Of these 63 patients, 43 (68.2%) achieved control of DM2 and were discharged without the need for antidiabetic medication, and 20 (31.7%) were discharged still on medication. One month after surgery, seven more patients discontinued medication for DM2, and 18 months after surgery, 97.6% of the patients showed control of DM2.

Conclusion

Gastric bypass is effective in controlling DM2 in morbid obese patients.

References

  1. 1.
    MacDonald KG Jr, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997;1:213–20; discussion 20.PubMedCrossRefGoogle Scholar
  2. 2.
    Sjostrom CD. Surgery as an intervention for obesity. Results from the Swedish obese subjects study. Growth Horm IGF Res 2003;13(Suppl A):S22–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89:2608–15.PubMedCrossRefGoogle Scholar
  4. 4.
    Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005;15:462–73.PubMedCrossRefGoogle Scholar
  5. 5.
    Lima J, Helena L, Oliveira S, et al. Rapid resolution of diabetes after gastric bypass. Obes Surg 2005;15:448–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Mason EE. Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999;9:223–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Mason EE. The mechanisms of surgical treatment of type 2 diabetes. Obes Surg 2005;15:459–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Patriti A, Facchiano E, Sanna A, et al. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 2004;14:840–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Pinkney JH, Sjostrom CD, Gale EA. Should surgeons treat diabetes in severely obese people? Lancet 2001;357:1357–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Pories WJ. Why does the gastric bypass control type 2 diabetes mellitus? Obes Surg 1992;2:303–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg 2001;25:527–31.PubMedCrossRefGoogle Scholar
  12. 12.
    Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339–50; discussion 50–2.PubMedCrossRefGoogle Scholar
  13. 13.
    Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002;236:554–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004;240:236–42.PubMedCrossRefGoogle Scholar
  16. 16.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.PubMedCrossRefGoogle Scholar
  17. 17.
    Ballantyne GH. Peptide YY(1–36) and peptide YY(3–36): Part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 2006;16:795–803.PubMedCrossRefGoogle Scholar
  18. 18.
    Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.CrossRefGoogle Scholar
  19. 19.
    Narayan KM, Gregg EW, Fagot-Campagna A, et al. Diabetes—a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 2000;50(Suppl 2):S77–84.PubMedCrossRefGoogle Scholar
  20. 20.
    Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1–11.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2007

Authors and Affiliations

  • Cláudio Corá Mottin
    • 1
    • 2
  • Alexandre Vontobel Padoin
    • 1
  • Caroline Eckerdt Schroer
    • 1
  • Fabiano Trentini Barancelli
    • 1
  • Luiz Glock
    • 1
  • Giuseppe Repetto
    • 1
  1. 1.Centro da Obesidade Mórbida—Hospital São Lucas da PUCRS (COM HSL/PUCRS)Porto AlegreBrazil
  2. 2.Porto AlegreBrazil

Personalised recommendations